INSIGHTS ON CRITICAL ENVIRONMENTS

• Getting More From Your Buffer Management Strategy

  A drug manufacturer was facing challenges in buffer management. By implementing innovative inline buffer formulation technology, they were able to save space, increase efficiency, and become more sustainable.

• Contamination Control Strategies For Innovation And Regulatory Compliance

  Creating a robust contamination control strategy is essential for pharmaceutical manufacturing. Learn to align risk management and technical controls to ensure lasting regulatory compliance.

• Technology-Led Expansion Of Oligonucleotide Capabilities

  Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.

• The Open Standard For Plug-And-Produce

  Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.

• Navigating The Paradigm Shift: Ensuring Efficacy In Risk-Based Cleaning Validation

  10/23/2024

  Unearth how adopting a risk-based approach to cleaning validation can enhance product quality, safety, and regulatory compliance in pharmaceutical manufacturing.

• Mastering Pharmaceutical Cleaning Validation Methods

  6/22/2026

  View the basics of cleaning validation and discuss the support services you should seek from your critical cleaning products supplier to optimize your cleaning validation process.

• Inside The Cleanroom: Disinfectant Validation Demystified With Neil Simpson

  2/12/2026

  Ensure cleanroom compliance by aligning disinfectant validation with real-world application methods. Learn to justify your protocols and adapt to facility changes through expert technical insights.

• Inside The Cleanroom: Building A Culture Of Clean Beyond The CCS Blueprint

  2/12/2026

  Achieving sterile excellence requires more than just rigid protocols. Learn how to foster a proactive mindset across your entire organization to ensure long-term facility integrity.

• A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies

  3/20/2026

  EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.